The use of vaccines for prevention of seasonal and pandemic influenzaArchived
On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.
Individual decision-making and childhood vaccination
ECDC organised a meeting among invited experts to exchange cross-disciplinary perspectives on the issue of MMR vaccination refusal among the general European population.
The United States Advisory Committee on Immunization Practices votes for near universal recommendation for seasonal influenza vaccinationArchived
The United States Advisory Committee on Immunization Practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on vaccine issues, voted to approve a new recommendation on February 24 to offer seasonal influenza vaccination to the whole population aged 6 months and older.
Virological Risk Assessment of Pandemic Potential - EFSA Call for proposalsArchived
The European Food Standard Agency has recently published a call for proposals for a methodological framework for potentially pandemic influenza strains.
Assessing vaccination coverage in the European Union: is it still a challenge?Archived
The authors review some of the different systems that are used for assessing vaccination coverage within and outside the EU in order to explore the need for improving vaccination coverage data quality.
WHO announcement of recommended strains to be included in the Southern Hemisphere 2012 influenza vaccine compositionArchived
The World Health Organization (WHO) recently recommended using the same three flu strains in next year's Southern Hemisphere (SH) vaccine as are in the current Northern Hemisphere vaccine and were used last year in southern hemisphere countries.
Rubella revisited: Where are we on the road to disease elimination in Central Europe?Archived
Elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for the WHO European Regional Office over the past decade. In 2010 the WHO regional committee for Europe renewed its commitment to the elimination of rubella and prevention of CRS with a new target of 2015. For Central Europe to reach the target of rubella elimination and prevention of CRS by 2015, very high vaccine coverage levels need to be maintained and catch-up campaigns continued to address susceptible groups, in particular women of child-bearing age.